G. Kopetzky

Erratum to: Iron metabolism and iron supplementation in cancer patients

M. Aapro, M. Steurer, M. Fridrik, 2015, Wiener klinische Wochenschrift.

Iron metabolism and iron supplementation in cancer patients

M. Aapro, M. Steurer, M. Fridrik, 2015, Wiener klinische Wochenschrift.

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF

M. Baccarani, H. Agis, A. Curti, 2011, Bone Marrow Transplantation.

Disseminated Infection with Nattrassia mangiferae in an Immunosuppressed Patient

A. Bankier, P. Apfalter, B. Willinger, 2004, Journal of Clinical Microbiology.

Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.

R. Greil, W. Scheithauer, T. Sliwa, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure

H. Greinix, A. Böhm, K. Gleixner, 2017, Journal of clinical apheresis.

Case Report: Pregnancy in a patient with recurrent glioblastoma

C. Marosi, C. Kurz, P. Balcke, 2013, F1000Research.

Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma

R. Valenta, W. Pickl, P. Waidhofer-Söllner, 2022, Vaccines.

Iron metabolism and iron supplementation in cancer patients

M. Aapro, M. Steurer, M. Fridrik, 2015, Wiener klinische Wochenschrift.